[Cytokines Summit 2022] Enabling Cytokine Therapeutic Development with Qualified, Functional Cell-Based Assays
- File Name/Number:
- Cytokines Summit
- Year:
- 2022
Gaurav Agrawal, Ph.D.Scientific Development Manager
- Discover how cell-based assays and translational services accelerate cytokine-based immunotherapeutic development from early discovery to GMP Lot Release Testing
- Learn about industry’s largest cell-based assay portfolio covering 80+ cytokine, interleukin and chemokine targets including IL-1, IL-2, IL-6, IL-7, IL-12, IL-15, IL-17, GM-CSF, CCRs, and CXCRs
- Delve into custom bioassay qualification case studies showing development of fit-for-purpose bioassays for potency, stability, and NAb testing
- Learn how method transfer support is critical for assay implementation at CRO sites
- Gain human insights early, with custom biomarker services and the BioMAP® Platform of cell-based disease models